ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 344 out of 2888

$1.16M Total Retail Price of All Prescriptions

Rank: 151 out of 2888

434 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 9,490 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 378 258 1 2
NAMENDA 372 366 2 34
LEVOTHYROXINE SODIUM 354 316 3 1
PRAVASTATIN SODIUM 322 243 4 12
ALENDRONATE SODIUM 304 271 5 23
AMLODIPINE BESYLATE 299 252 6 5
LISINOPRIL 284 188 7 3
FUROSEMIDE 267 222 8 6
DONEPEZIL HCL 240 234 9 26
HYDROCODONE-ACETAMINOPHEN 220 174 S3 10 4
EXELON 191 180 11 106
EVISTA 186 155 12 125
ZOLPIDEM TARTRATE 185 112 13 17
SERTRALINE HCL 181 135 14 27
GABAPENTIN 175 116 15 13
TRAMADOL HCL 172 116 16 16
METOPROLOL TARTRATE 171 163 17 10
HYDROCHLOROTHIAZIDE 158 136 18 15
CYMBALTA 154 124 19 44
LANTUS 153 88 20 45
METFORMIN HCL 152 75 21 8
METFORMIN HCL ER 144 99 22 53
SPIRIVA 144 114 22 79
TAMSULOSIN HCL 142 126 24 29
CARVEDILOL 142 113 24 21
NEXIUM 142 108 24 19
OMEPRAZOLE 141 124 27 7
OLANZAPINE 119 76 28 137
POTASSIUM CHLORIDE 117 103 29 14
FENOFIBRATE 113 83 30 65
ADVAIR DISKUS 113 90 30 60
ATORVASTATIN CALCIUM 105 77 32 9
TRAZODONE HCL 103 58 33 43
CLOPIDOGREL 96 73 34 30
NOVOLIN R 93 75 35 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 69 36 28
ATENOLOL 87 52 37 25
PANTOPRAZOLE SODIUM 84 75 38 33
ALBUTEROL SULFATE 80 72 39 134
TRIAMTERENE-HCTZ 80 73 39 63
LEVEMIR 77 50 41 135
CRESTOR 76 55 42 20
PLAVIX 75 63 43 40
JANUVIA 74 42 44 48
QUETIAPINE FUMARATE 70 60 45 66
RISPERIDONE 70 25 45 72
FLUOXETINE HCL 70 48 45 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 49 48 88
ESCITALOPRAM OXALATE 65 30 49 62
OXYBUTYNIN CHLORIDE ER 64 52 50 132
CLONIDINE HCL 59 51 51 39
AZITHROMYCIN 58 39 52 38
KLOR-CON M20 58 57 52 90
KLOR-CON M10 57 35 54 118
ISOSORBIDE MONONITRATE ER 56 55 55 51
AMOX TR-POTASSIUM CLAVULANATE 56 42 55 112
PROMETHAZINE HCL 54 34 R 57 96
WARFARIN SODIUM 53 48 58 22
FINASTERIDE 53 34 58 102
METOCLOPRAMIDE HCL 51 43 60 116
DILTIAZEM 24HR CD 50 47 61 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.